Story M - Search Results

1

Stereotactic body radiation therapy: normal tissue and tumor control effects with large dose per fraction.

Timmerman R, Bastasch M, Saha D, Abdulrahman R, Hittson W, Story M. Timmerman R, et al. Among authors: story m. Front Radiat Ther Oncol. 2011;43:382-394. doi: 10.1159/000322494. Epub 2011 May 20. Front Radiat Ther Oncol. 2011. PMID: 21625164 Review.

2

Stereotactic body radiation therapy: a treatment in need of basic biological research.

Timmerman RD, Story M. Timmerman RD, et al. Among authors: story m. Cancer J. 2006 Jan-Feb;12(1):19-20. doi: 10.1097/00130404-200601000-00004. Cancer J. 2006. PMID: 16613657 No abstract available.

3

Optimizing dose and fractionation for stereotactic body radiation therapy. Normal tissue and tumor control effects with large dose per fraction.

Timmerman R, Bastasch M, Saha D, Abdulrahman R, Hittson W, Story M. Timmerman R, et al. Among authors: story m. Front Radiat Ther Oncol. 2007;40:352-365. doi: 10.1159/000106046. Front Radiat Ther Oncol. 2007. PMID: 17641519 Review.

4

Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.

Park C, Papiez L, Zhang S, Story M, Timmerman RD. Park C, et al. Among authors: story m. Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):847-52. doi: 10.1016/j.ijrobp.2007.10.059. Int J Radiat Oncol Biol Phys. 2008. PMID: 18262098

5

Exploring the possibility of unique molecular, biological, and tissue effects with hypofractionated radiotherapy.

Story M, Kodym R, Saha D. Story M, et al. Semin Radiat Oncol. 2008 Oct;18(4):244-8. doi: 10.1016/j.semradonc.2008.04.006. Semin Radiat Oncol. 2008. PMID: 18725111

6

The small-molecule CDK inhibitor, SNS-032, enhances cellular radiosensitivity in quiescent and hypoxic non-small cell lung cancer cells.

Kodym E, Kodym R, Reis AE, Habib AA, Story MD, Saha D. Kodym E, et al. Lung Cancer. 2009 Oct;66(1):37-47. doi: 10.1016/j.lungcan.2008.12.026. Epub 2009 Feb 3. Lung Cancer. 2009. PMID: 19193471

7

SNS-032 prevents hypoxia-mediated glioblastoma cell invasion by inhibiting hypoxia inducible factor-1alpha expression.

Ali MA, Reis A, Ding LH, Story MD, Habib AA, Chattopadhyay A, Saha D. Ali MA, et al. Among authors: story md. Int J Oncol. 2009 Apr;34(4):1051-60. doi: 10.3892/ijo_00000231. Int J Oncol. 2009. PMID: 19287962

8

An orthotopic lung tumor model for image-guided microirradiation in rats.

Saha D, Watkins L, Yin Y, Thorpe P, Story MD, Song K, Raghavan P, Timmerman R, Chen B, Minna JD, Solberg TD. Saha D, et al. Radiat Res. 2010 Jul;174(1):62-71. doi: 10.1667/RR2157.1. Radiat Res. 2010. PMID: 20681800 Free PMC article.

9

Molecular profiling to optimize treatment in non-small cell lung cancer: a review of potential molecular targets for radiation therapy by the translational research program of the radiation therapy oncology group.

Ausborn NL, Le QT, Bradley JD, Choy H, Dicker AP, Saha D, Simko J, Story MD, Torossian A, Lu B. Ausborn NL, et al. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e453-64. doi: 10.1016/j.ijrobp.2012.01.056. Epub 2012 Apr 18. Int J Radiat Oncol Biol Phys. 2012. PMID: 22520478 Review.

10

The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions.

Laine AM, Pompos A, Timmerman R, Jiang S, Story MD, Pistenmaa D, Choy H. Laine AM, et al. Front Oncol. 2016 Jan 11;5:302. doi: 10.3389/fonc.2015.00302. eCollection 2015. Front Oncol. 2016. PMID: 26793619 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

709 results

Search Page

Filters